SCHEMBL831930

SCHEMBL831930

CCn1c(C(=O)NS(=O)(=O)c2cccc(N)c2)c(-c2ccc[nH]c2=O)c2cc(Cl)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 7/20 0.37
FLT4 P35916 7/20 0.37
KDR P35968 7/20 0.37
PTGER4 P35408 1/20 0.37
PPARG P37231 4/20 0.36
RORC P51449 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C8 P10632 1/20 0.35
KMT2A Q03164 1/20 0.35
LOXL2 Q9Y4K0 2/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PTPRC P08575 1/20 0.34
PTPN1 P18031 1/20 0.34
PTPRG P23470 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL862372 0.89 ALDH1A1 (0.41) FLT1FLT4KDRPPARGKDM4E
SCHEMBL862443 0.88 TDP2 (0.36) FLT1FLT4KDRPTGER4PPARG
SCHEMBL831696 0.86 PPARG (0.38) FLT1FLT4KDRPPARGCYP2C8
SCHEMBL831565 0.85 ALDH1A1 (0.40) PTGER4PPARGRORCKDM4EALDH1A1
SCHEMBL832230 0.81 KMT2A (0.39) FLT1FLT4KDRPTGER4PPARG
SCHEMBL862717 0.81 CYP2C8 (0.42) FLT1FLT4KDRPPARGCYP2C8
SCHEMBL862296 0.81 PPARG (0.41) PPARGCYP2C8KMT2A
SCHEMBL862488 0.81 SERPINE1 (0.38) FLT1FLT4KDRPPARGCYP2C8
SCHEMBL862158 0.80 CYP2C8 (0.41) FLT1FLT4KDRPPARGCYP2C8
SCHEMBL862476 0.80 PPARG (0.36) FLT1FLT4KDRPPARGKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143305-B2 2,3-substituted indole derivatives for treating viral infections SCHERING CORPORATION (US) 2012-03-27 US disclosed
US-8143305-B2 2,3-substituted indole derivatives for treating viral infections SCHERING CORPORATION (US) 2012-03-27 US disclosed
US-20110033417-A1 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS MERCK SHARP & DOHME CORP. 2011-02-10 US disclosed
US-20110033417-A1 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS MERCK SHARP & DOHME CORP. 2011-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110033417-A1 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS IDO2, IDO1, IRF3 FLT1 3635/4885FLT4 2781/4885KDR 3494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.